在格鲁吉亚的儿科烧伤:对医院数据的八年回顾性研究
M Andriadze1, M Kereselidze2, N Chkhaberidze2
11Ivane Javakhishvili Tbilisi State University, Georgia.
Georgian medical news
|January 9, 2026
概括
儿童烧伤是格鲁吉亚的主要公共卫生问题,大多数病例发生在婴儿身上. 这项研究揭示了烧伤的季节性高峰,特别是在冬季和夏季,突出了针对性预防策略的需要.
科学领域:
- 儿科医学 儿科医学 儿科医学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 烧伤造成的伤害对全球的健康构成重大挑战,尤其对儿童来说.
- 在格鲁吉亚,以前没有对儿科烧伤的综合流行病学研究.
研究的目的:
- 分析格鲁吉亚儿科烧伤的流行病学.
- 为了确定频率,分布和结果的模式.
主要方法:
- 使用国家住院数据 (2017-2024) 的回顾性观察性研究.
- 包括0-17岁的患者,被诊断患有烧伤.
- 分析了人口统计,烧伤病因,严重程度,住院时间和季节性分布.
主要成果:
- 确定了5,268例儿科烧伤病例;大多数是1岁以下的男性.
- 热烧伤最常见 (90.9%);第二度和第三度烧伤占主导地位.
- 在12月和7月观察到季节性高峰,特别是在幼儿 (0-5岁).
结论:
- 这是格鲁吉亚关于儿科烧伤的首次全国性研究,揭示了显著的流行病学模式.
- 调查结果强调需要针对季节性变化制定预防策略.
- 为了有效的干预,建议对详细数据进行进一步的研究.
相关概念视频
Burn Injuries
4.1K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
240
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
240
Pharmacokinetics in Pediatric Patients: Drug Metabolism
189
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189
Drug Dosing: Infants and Children
248
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
248
Pharmacokinetics in Pediatric Patients: Drug Distribution
251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251


